The generic version could ease the cost burden for uninsured Canadians.
A lower-cost version of Ozempic may soon change the game for Canadians struggling without drug coverage.The widely used diabetes and weight-management drug has remained out of reach for many due to high monthly costs.Patients without insurance have been forced to delay treatment or make financial sacrifices.
A generic alternative could significantly reduce prices, improving access for thousands.However, experts warn that availability and pricing will depend on regulatory approvals and provincial policies.While this marks progress, it also highlights a deeper issue of gaps in Canada’s drug coverage system.
For many, this is not just about one medication. It’s about whether essential treatments should depend on income at all.
